|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/7088 | (2006.01) |
| A61K 31/7088 | (2013.01) | ||
| A61K 31/711 | (2006.01) | ||
| A61K 31/711 | (2013.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 35/02 | (2018.01) |
| (11) | Number of the document | 3512525 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17851584.7 |
| Date of filing the European patent application | 2017-09-15 | |
| (97) | Date of publication of the European application | 2019-07-24 |
| (45) | Date of publication and mention of the grant of the patent | 2022-07-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/051723 |
| Date | 2017-09-15 |
| (87) | Number | WO 2018/053232 |
| Date | 2018-03-22 |
| (30) | Number | Date | Country code |
| 201662395680 P | 2016-09-16 | US | |
| 201762487277 P | 2017-04-19 | US |
| (72) |
ASHIZAWA, Ana Tari , US
|
| (73) |
Bio-Path Holdings, Inc. ,
4710 Bellaire Boulevard
Suite 210, Bellaire, TX 77401,
US
|
| (54) | COMBINATION THERAPY WITH LIPOSOMAL ANTISENSE OLIGONUCLEOTIDES |
| COMBINATION THERAPY WITH LIPOSOMAL ANTISENSE OLIGONUCLEOTIDES |